Ophthalmological effects of high altitude

Ophthalmic Research

Volumn 32, Issue 1, 2000, Pages 30-40

  Karaküçük, Sarper ^a   Mirza, G Ertuǧrul ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Aerospace medicine; Altitude sickness; Aviation; Intraocular pressure; Mountaineering

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; PENTOXIFYLLINE; STEROID;

ACCOMMODATION; AEROSPACE MEDICINE; ALTITUDE DISEASE; ARTICLE; AVIATION; CATARACT; CLIMATOTHERAPY; CONJUNCTIVA; CONTACT LENS; CORNEA SURGERY; EDEMA; EYE DISEASE; HUMAN; INTRAOCULAR PRESSURE; MOUNTAINEERING; PRIORITY JOURNAL; REFRACTIVE KERATOPLASTY; RETINA SURGERY; SPORTS MEDICINE; UVEITIS;

EID: 0342545468     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055584     Document Type: Article

References (110)

1. Pigman EC: Acute mountain sickness: Effects and implications for exercise at intermediate altitudes. Sports Med 1991;12:71-79.
2. Houston CS: From the mountains to the labs: A brief summary of the people and their studies on which rests most of what we know today. Int J Sports Med 1992;13:S6-S9.
3. Singh I, Khanna PK, Srivastava MC, Lal M, Roy SB, Subramanyam CS: Acute Mountain Sickness. N Engl J Med 1969;280:175-184.
4. Hackett PH, Rennie D, Levine HD: The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976;ii:1149-1154.
5. Carson RP, Evans WO, Shields JL, Hannon JP: Symptomatology, pathophysiology, and treatment of acute mountain sickness. Fed Proc 1969;28:1085-1091.
6. Sutton JR, Lazarus E: Mountain sickness in the Australian Alps. Med J Aust 1973;1:545-546.
7. Butler FK, Harris DJ Jr, Reynolds RD: Altitude retinopathy on Mount Everest, 1989. Ophthalmology 1992;99:739-746.
8. Porcelli MJ, Gugelchuk GM: A trek to the top: A review of acute mountain sickness. J Am Osteopath Assoc 1995;95:718-720.
9. Ergun Y: Cases of acute mountain sickness on Mount Agri. Br J Clin Pract 1994;48:152-155.
10. Kobayashi T, Koyama S, Kubo K, Fukushima M, Kusama S: Clinical features of patients with high-altitude pulmonary edema in Japan. Chest 1987;92:814-821.
11. Houston CS, Dickinson J: Cerebral form of high-altitude illness. Lancet 1975;ii:758-761.
12. Bartsch P: High altitude pulmonary edema. Respiration 1997;64:435-443.
13. Clarke C: High altitude cerebral oedema. Int J Sports Med 1988;9:170-174.
14. Guijarro Morales A, Gil Extremera B, Maldonado Martin A: Acute mountain sickness. An Med Interna 1990;7:375-378.
15. Houston CS: Operation Everest one and two. Respiration 1997;64:398-406.
16. Meehan RT, Zavala DC: The pathophysiology of acute high-altitude illness. Am J Med 1982; 73:395-403.
17. Savard GK, Areskog NH, Saltin B: Cardiovascular response to exercise in humans following acclimatization to extreme altitude. Acta Physiol Scand 1995;154:499-509.
18. Doughty HA, Beardmore C: Bleeding time at altitude. J R Soc Med 1994;87:317-319.
19. de Meer K, Heymans HS, Zijlstra WG: Physical adaptation of children to life at high altitude. Eur J Pediatr 1995;154:263-272.
20. Le Roux G, Larmignat P, Marchal M, Richalet JP: Haemostasis at high altitude. Int J Sports Med 1992;13(suppl 1):S49-S51.
21. Rupwate RU, Chitaley M, Kamat SR: Cardiopulmonary functional changes in acute acclimatisation to high altitude in mountaineers. Eur J Epidemiol 1990;6:266-272.
22. Sagawa S, Torii R, Nagaya K, Wada F, Endo Y, Shiraki K: Carotid baroreflex control of heart rate during acute exposure to simulated altitudes of 3,800 m and 4,300 m. Am J Physiol 1997;273:R1219-1223.
23. Mazzeo RS, Child A, Butterfield GE, Mawson JT, Zamudio S, Moore LG: Catecholamine response during 12 days of high-altitude exposure (4,300 m) in women. J Appl Physiol 1998; 84:1151-1157.
24. Rostrup M: Catecholamines, hypoxia and high altitude. Acta Physiol Scand 1998;162:389-399.
25. Basu CK, Gautam RK, Sharma RP, Kumar H, Tomar OS, Sawhney RC, Selvamurthy W: Metabolic responses during initial days of altitude acclimatization in the eastern Himalayas. Int J Biometeorol 1996;39:133-138.
26. Cogo A, Legnani D, Allegra L: Respiratory function at different altitudes. Respiration 1997;64:416-421.
27. Shufflebarger C, Jehle D, Cottington E, Martin M: Transconjunctival oxygen monitoring as a predictor of hypoxemia during helicopter transport. Am J Emerg Med 1986;4:501-503.
28. Guo L, Su G: A preliminary report on changes in micro-circulation of conjunctiva in patients with high altitude pulmonary edema. Chung Hua Yen Ko Tsa Chih 1995;31:285-287.
29. Mader TH, Friedl KE, Mohr LC, Bernhard WN: Conjunctival oxygen tension at high altitude. Aviat Space Environ Med 1987;58:76-79.
30. Mader TH, Blanton CL, Gilbert BN, Kubis KC, Schallhorn SC, White LJ, Parmley VC, Ng JD: Refractive changes during 72 hour exposure to high altitude after refractive surgery. Ophthalmology 1996;103:1188-1195.
31. Mader TH, White LJ: Refractive changes at extreme altitude after radial keratotomy. Am J Ophthalmol 1995;119:733-737.
32. Ng JD, White LJ, Parmley VC, Hubickey W, Carter J, Mader TH: Effects of simulated high altitude on patients who have had radial keratotomy. Ophthalmology 1996;103:452-457.
33. Şimşek S, Demirok A, Cinal A, Yaşar T, Yilmaz ÖF: The effect of altitude on radial keratotomy. Jpn J Ophthalmol 1998;42:119-123.
34. Creel DJ, Crandall AS, Swartz M: Hyperopic shift induced by high altitude after radial keratotomy. J Refract Surg 1997;13:398-400.
35. Winkle RK, Mader TH, Parmley VC, White LJ, Polse KA: The etiology of refractive changes at high altitude after radial keratotomy: Hypoxia versus hypobaria. Ophthalmology 1998;105:282-286.
36. Mastropasqua L, Ciancaglini M, Di Tano G, Carpineto P, Lobefalo L, Loffredo B, Bosco D, Columbaro M, Falcieri E: Ultrastructural changes in rat cornea after prolonged hypobaric hypoxia. J Submicrosc Cytol Pathol 1998; 30:285-293.
37. Davidorf JM: LASIK at 16,000 feet. Ophthalmology 1997;104:565-566.
38. Stratas B, Peterson CF: Refractive stability of LASIK. Ophthalmology 1997;104:1726-1727.
39. Kramar PO, Drinkwater BL, Folinsbee LJ, Bedi JF: Ocular functions and incidence of acute mountain sickness in women at altitude. Aviat Space Environ Med 1983;54:116-120.
40. Allemann Y, Saner H, Meier B: High altitude stay and air travel in coronary heart disease. Schweiz Med Wochenschr 1998;128:671-678.
41. Koch DD, Knauer WJ 3rd, Emery JM: High altitude corneal endothelial decompensation. Cornea 1984-85;3:189-191.
42. Castren J, Tuovinen E, Lansimies E, Stenborg T, Aho J, Nedrum K: Contact lenses in hypoxia. Acta Ophthalmol 1985;63:439-442.
43. Polishuk A, Raz D: Soft hydrophilic contact lenses in civil and military aviation. Aviat Space Environ Med 1975;46:1188-1190.
44. Hapnes R: Soft contact lenses worn at a simulated altitude of 18,000 feet. Acta Ophthalmol (Copenh) 1980;58:90-95.
45. Hu TS, Zhen Q, Sperduto RD, Zhao JL, Milton RC, Nakajima A: Age-related cataract in the Tibet Eye Study. Arch Ophthalmol 1989;107: 666-669.
46. Chatterjee A, Rambo VC, Franken S: Vision survey in Himalayan area. Am J Ophthalmol 1968;66:113-116.
47. Brandt F, Bishwas IC, Pradhan YM: Ophthalmologic findings and problems in West Nepal. Klin Monatsbl Augenheilkd 1982;181:295-298.
48. Brandt F, Malla OK, Pradhan YM, Prasad LN, Rai NC, Pokharel RP, Lakhe S: Incidence of cataracts in the mobile eye hospitals of Nepal. Graefes Arch Clin Exp Ophthalmol 1982;218: 25-27.
49. Harding JJ: The untenability of the sunlight hypothesis of cataractogenesis. Doc Ophthalmol 1994-95;88:345-349.
50. Fang HS, Chen HM: Decompression and occurrence of cataract in enucleated eyes of experimental animals. Aviat Space Environ Med 1987;58:992-995.
51. Fang HS, Chen HM: Bubble formation of aqueous humor and lens opacity during chamber flight. Aviat Space Environ Med 1984;55: 910-913.
52. Mader TH, Carey WG, Friedl KE, Wilson WR: Intraocular lenses in aviators: A review of the US Army experience. Aviat Space Environ Med 1987;58:690-694.
53. Brinchmann-Hansen O, Myhre K: Blood pressure, intraocular pressure, and retinal vessels after high altitude mountain exposure. Aviat Space Environ Med 1989;60:970-976.
54. Clarke C, Duff J: Mountain sickness, retinal hemorrhages and acclimatisation on Mount Everest in 1975. Br Med J 1976;ii:495-497.
55. Carapancea M: Experimental and clinical hyperophthalmotony of high altitudes. Arch Ophtalmol Rev Gen Ophthalmol 1977;37:775-784.
56. Jones W, White RE, Magnus DE: Increased occurrence of exfoliation in the male, Spanish American population of New Mexico. J Am Optom Assoc 1992;63:643-648.
57. Kozobolis VP, Papatzanaki M, Vlachonikolis IG, Pallikaris IG, Tsambarlakis I: Epidemiology of pseudoexfoliation in the island of Crete (Greece). Acta Ophthalmol Scand 1997;75: 726-729.
58. Ortiz GJ, Cook DJ, Yablonski ME, Masonson H, Harmon G: Effect of cold air on aqueous humor dynamics in humans. Inv Ophthalmol Vis Sci 1988;29:138-140.
59. Draeger J, Schwartz R, Groenhoff S, Stern C: Self-tonometry under microgravity conditions. Clin Invest 1993;71:700-713.
60. Mader TH, Taylor GR, Hunter N, Caputo M, Meehan RT: Intraocular pressure, retinal vascular, and visual acuity changes during 48 hours of 10 degrees head-down tilt. Aviat Space Environ Med 1990;61:810-813.
61. McFadden DM, Houston CS, Sutton JR, Powles AC, Gray GW, Roberts RS: High-altitude retinopathy. JAMA 1981;245:581-586.
62. Lang GE, Kuba GB: High-altitude retinopathy. Am J Ophthalmol 1997;123:418-420.
63. Botella de Maglia J, Martinez-Costa R: High altitude retinal hemorrhages in the expeditions to 8,000 meter peaks: A study of 10 cases. Med Clin (Barc) 1998;110:457-461.
64. MacLaren RE: Retinal haemorrhage in Himalayan mountaineers. J R Army Med Corps 1995;141:25-28.
65. Frayser R, Houston CS, Bryan AC, Rennie ID, Gray G: Retinal hemorrhage at high altitude. N Engl J Med 1970;282:1183-1184.
66. Braun U, Braun M, Jonas JB: Höhenretinopathie nach Himalaya-Aufenthalt. Klin Monatsbl Augenheilkd 1997;211:213-214.
67. Wiedman M: High altitude retinal hemorrhage. Arch Ophthalmol 1975;93:401-403.
68. Zhang DQ, Qu Z: Fundus examination of newborns on Tibet plateau. Chung Hua Yen Ko Tsa Chih 1989;25:200-202.
69. Liu X, Cheng G, Yang S, Ling Y, Ke P: Retinal hemorrhage in newborn infants. Yen Ko Hsueh Pao 1993;9:200.
70. Govind A, Kumari S, Lath NK: Retinal hemorrhages in newborn. Indian Pediatr 1989;26: 150-152.
71. Kaur B, Talor D: Fundus hemorrhages in infancy. Surv Ophthalmol 1992;37:1-17.
72. Rimsza ME, Hernried LS, Kaplan AM: Hemorrhagic retinopathy in a patient with cystic fibrosis. Pediatrics 1978;62:336-338.
73. Rennie D, Morrissey J: Retinal changes in Himalayan climbers. Arch Ophthalmol 1975;93: 395-400.
74. Shults WT, Swan KC: High altitude retinopathy in mountain climbers. Arch Ophthalmol 1975;93:404-408.
75. Schumacher GA, Petajan JH: High altitude stress and retinal hemorrhage: Relation to vascular headache mechanisms. Arch Environ Health 1975;30:217-221.
76. Balcet U, Rossaro S, Fiorani V: Altitude-induced retinal hemorrhages: A new aspect of mountain sickness. Minerva Med 1981;72: 1785-1798.
77. Lubin JR, Rennie D, Hackett P, Albert DM: High altitude retinal hemorrhage: A clinical and pathological case report. Ann Ophthalmol 1982;14:1071-1076.
78. Daniele S, Daniele C: Aggravation of laser-treated diabetic cystoid macular edema after prolonged flight: A case report. Aviat Space Environ Med 1995;66:440-442.
79. Brandl H, Lachenmayr B: Dependence of the sensitivity of the central visual field on hemoglobin-oxygen saturation. Ophthalmologe 1994;91:151-155.
80. von Restorff W, Hebisch S: Dark adaptation of the eye during carbon monoxide exposure in smokers and nonsmokers. Aviat Space Environ Med 1988;59:928-931.
81. Daubs J: Flight crew exposure to ozone concentrations affecting the visual system. Am J Optom Physiol Opt 1980;57:95-105.
82. Carapancea M: ERG scotopic manifestation and their determinism, in experimental conditions of high altitude. Vision Res 1971;11: 1219.
83. Schmeisser ET, Gagliano DL, Santiago-Marini J: Visual system effects of exercise on Mauna Kea at 2,200 and 4,200 meters altitude. Mil Med 1997;162:186-189.
84. Brinchmann-Hansen O, Myhre K, Sandvik L: Retinal vessel responses to exercise and hypoxia before and after high altitude acclimatisation. Eye 1989;3:768-776.
85. Meehan RT, Taylor GR, Rock P, Mader TH, Hunter N, Cymerman A: An automated method of quantifying retinal vascular responses during exposure to novel environmental conditions. Ophthalmology 1990;97:875-881.
86. Brinchmann-Hansen O, Myhre K: The effect of hypoxia upon macular recovery time in normal humans. Aviat Space Environ Med 1989;60: 1183-1186.
87. Richalet JP, Duval-Arnould G, Darnaud B, Keromes A, Rutgers V: Modification of colour vision in the green/red axis in acute and chronic hypoxia explored with a portable anomaloscope. Aviat Space Environ Med 1988;59: 620-623.
88. Watts P, Karakucuk S, McAllister J: Measurement of the retinal nerve fiber layer thickness with a nerve fiber analyzer in normal subjects. Lasers Light 1996;7:79-84.
89. Leber LL, Roscoe SN, Southward GM: Mild hypoxia and visual performance with night vision goggles. Aviat Space Environ Med 1986; 57:318-324.
90. Hanscom TA, Diddie KR: Mountain travel and intraocular gas bubbles. Am J Ophthalmol 1987;104:546.
91. Jackman SV, Thompson JT: Effects of hyperbaric exposure on eyes with intraocular gas bubbles. Retina 1995;15:160-166.
92. Aronowitz JD, Brubaker RF: Effect of intraocular gas on intraocular pressure. Arch Ophthalmol 1976;94:1191-1196.
93. Kokame GT, Ing MR: Intraocular gas and low-altitude air flight. Retina 1994;14:356-358.
94. Lincoff H, Weinberger D, Reppucci V, Lincoff A: Air travel with intraocular gas. I. The mechanisms for compensation. Arch Ophthalmol 1989;107:902-906.
95. Lincoff H, Weinberger D, Stergiu P: Air travel with intraocular gas. II. Clinical considerations. Arch Ophthalmol 1989;107:907-910.
96. Dieckert JP, O'Connor PS, Schacklett DE, Tredici TJ, Lambert HM, Fanton JW, Sipperley JO, Rashid ER: Air travel and intraocular gas. Ophthalmology 1986;93:642-645.
97. Frank P, Draeger J: Ophthalmologic implants -A risk at high altitudes? Klin Monatsbl Augenheilkd 1986;189:477-478.
98. Colvin J, Langford S, Emonson D, Kister M: Initial management and transport of patients with perforating eye injuries. Aust Fam Physician 1995;24:1017-1020.
99. Reeves W: Aeromedical evacuation of ophthalmic patients. Insight 1994;19:20-23.
100. Cepilova Z, Porubska M, Slamova J: Climate therapy of uveitis in a mountain environment. Cesk Oftalmol 1993;49:90-94.
101. Severinghaus JW: Hypothesis: Angiogenesis cytokines in high altitude cerebral oedema. Acta Anaesthesiol Scand Suppl 1995;107: 177-178.
102. Billington DC: Angiogenesis and its inhibition: Potential new therapies in oncology and non-neoplastic diseases. Drug Des Discov 1991;8:3-35.
103. Wolff JE, Guerin C, Laterra J, Bressler J, Indurti RR, Brem H, Goldstein GW: Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res 1993;604:79-85.
104. Meehan RT, Cymerman A, Rock P, Fulco CS, Hoffman J, Abernathy C, Needleman S, Maher JT: The effect of naproxen on acute mountain sickness and vascular responses to hypoxia. Am J Mod Sci 1986;292:15-20.
105. McIntosh IB, Prescott RJ: Acetazolamide in prevention of acute mountain sickness. J Int Med Res 1986;14:285-287.
106. Greene MK, Kerr AM, McIntosh IB, Prescott RJ: Acetazolamide in prevention of acute mountain sickness: A double-blind controlled cross-over study. Br Med J (Clin Res Ed) 1981;283:811-813.
107. Mountain RD: High-altitude medical problems. Clin Orthop 1987;216:50-54.
108. Ward A, Clissold SP: Pentoxifylline: A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987;34:50-97.
109. Klocke DL, Decker WW, Stepanek J: Altitude-related illnesses. Mayo Clin Proc 1998; 73:988-992.
110. Jacobson ND: Acute high-altitude illness. Am Fam Physician 1988;38:135-144.